Immunization with TG4010 appears biologically active in prostate cancer. Comment
Publication
, Other
Dahm, P; Moul, JW
Published in: Oncology Report
September 1, 2005
Duke Scholars
Published In
Oncology Report
EISSN
1548-5323
ISSN
1548-5323
Publication Date
September 1, 2005
Issue
FALL
Start / End Page
56
Related Subject Headings
- Oncology & Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Dahm, P., & Moul, J. W. (2005). Immunization with TG4010 appears biologically active in prostate cancer. Comment. Oncology Report.
Dahm, P., and J. W. Moul. “Immunization with TG4010 appears biologically active in prostate cancer. Comment.” Oncology Report, September 1, 2005.
Dahm P, Moul JW. Immunization with TG4010 appears biologically active in prostate cancer. Comment. Oncology Report. 2005. p. 56.
Dahm, P., and J. W. Moul. “Immunization with TG4010 appears biologically active in prostate cancer. Comment.” Oncology Report, no. FALL, 1 Sept. 2005, p. 56.
Dahm P, Moul JW. Immunization with TG4010 appears biologically active in prostate cancer. Comment. Oncology Report. 2005. p. 56.
Published In
Oncology Report
EISSN
1548-5323
ISSN
1548-5323
Publication Date
September 1, 2005
Issue
FALL
Start / End Page
56
Related Subject Headings
- Oncology & Carcinogenesis